相似文献
1
Critical limb ischemia: advanced medical therapy.严重肢体缺血：先进的药物治疗
Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):3-9. doi: 10.14797/mdcj-8-4-3.
2
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).高危进展期外周动脉疾病患者行斑块切除术联合强化药物治疗的长期结果（SAVE a LEG 注册研究）。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E244-50. doi: 10.1002/ccd.24756. Epub 2013 Mar 9.
3
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.保肢手术中的危险因素、医学治疗及围手术期事件：来自PREVENT III多中心试验的观察结果
J Vasc Surg. 2005 Sep;42(3):456-64; discussion 464-5. doi: 10.1016/j.jvs.2005.05.001.
4
Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.CRITISCH注册研究中他汀类药物治疗与严重肢体缺血患者无截肢生存率之间的关联。
J Vasc Surg. 2017 Nov;66(5):1534-1542. doi: 10.1016/j.jvs.2017.05.115. Epub 2017 Aug 12.
5
Medical management for chronic atherosclerotic peripheral arterial disease.慢性动脉粥样硬化性外周动脉疾病的医学管理。
Drugs. 2012 Nov 12;72(16):2073-85. doi: 10.2165/11640810-000000000-00000.
6
[Peripheral arterial disease: Treatment].[外周动脉疾病：治疗]
Presse Med. 2018 Jan;47(1):56-61. doi: 10.1016/j.lpm.2017.09.019. Epub 2017 Dec 19.
7
Aortic atherosclerotic disease and stroke.主动脉粥样硬化疾病与中风。
Circulation. 2006 Jul 4;114(1):63-75. doi: 10.1161/CIRCULATIONAHA.105.593418.
8
Pharmacological interventions on critical limb ischemia in diabetic patients.糖尿病患者严重肢体缺血的药物干预
J Cardiovasc Surg (Torino). 2012 Feb;53(1):39-43.
9
Optimal medical management in patients undergoing peripheral vascular interventions for chronic limb-threatening ischemia is associated with improved outcomes.对慢性肢体威胁性缺血行外周血管介入治疗的患者进行最佳的医学管理与改善治疗结果相关。
J Vasc Surg. 2023 Aug;78(2):490-497. doi: 10.1016/j.jvs.2023.04.025. Epub 2023 May 6.
10
Reperfusion strategies in the management of extremity vascular injury with ischaemia.肢体血管损伤伴缺血的再灌注策略。
Br J Surg. 2012 Jan;99 Suppl 1:66-74. doi: 10.1002/bjs.7790.
引用本文的文献
1
Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.股动脉以下动脉粥样硬化疾病所致严重肢体缺血的动脉血运重建治疗现状
Int J Angiol. 2018 Sep;27(3):132-137. doi: 10.1055/s-0037-1620242. Epub 2018 Jan 22.
本文引用的文献
1
Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis.围手术期使用他汀类药物对死亡、心肌梗死、心房颤动及住院时间的影响：一项系统评价与荟萃分析
Arch Surg. 2012 Feb;147(2):181-9. doi: 10.1001/archsurg.2011.897.
2
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会（ACCF/AHA）重点更新内容纳入《美国心脏病学会/美国心脏协会（ACC/AHA）2007年不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南》：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 May 10;123(18):e426-579. doi: 10.1161/CIR.0b013e318212bb8b. Epub 2011 Mar 28.
3
Long-term effects of intensive glucose lowering on cardiovascular outcomes.强化血糖控制对心血管结局的长期影响。
N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.
4
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.
5
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.随机、安慰剂对照氯吡格雷和阿司匹林在周围动脉疾病旁路手术中的应用（CASPAR）试验结果。
J Vasc Surg. 2010 Oct;52(4):825-33, 833.e1-2. doi: 10.1016/j.jvs.2010.04.027. Epub 2010 Aug 1.
6
Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.基础科学综述：他汀类药物治疗——第一部分：他汀类药物在心血管疾病中的多效性作用
Vasc Endovascular Surg. 2010 May;44(4):241-51. doi: 10.1177/1538574410362922.
7
Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.外周动脉疾病患者的抗血小板和抗血栓治疗。
Int Angiol. 2010 Feb;29(1):20-6.
8
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).非心脏手术术前心脏风险评估及围手术期心脏管理指南：欧洲心脏病学会（ESC）非心脏手术术前心脏风险评估及围手术期心脏管理特别工作组制定，并得到欧洲麻醉学会（ESA）认可。
Eur J Anaesthesiol. 2010 Feb;27(2):92-137. doi: 10.1097/EJA.0b013e328334c017.
9
2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.2009年美国心脏病学会基金会/美国心脏协会关于围手术期β受体阻滞剂的重点更新纳入《美国心脏病学会/美国心脏协会2007年非心脏手术围手术期心血管评估和治疗指南》：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2009 Nov 24;120(21):e169-276. doi: 10.1161/CIRCULATIONAHA.109.192690. Epub 2009 Nov 2.
10
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.非心脏手术术前心脏风险评估及围手术期心脏管理指南
Eur Heart J. 2009 Nov;30(22):2769-812. doi: 10.1093/eurheartj/ehp337. Epub 2009 Aug 27.
Zotero 插件